Dr David Hughes
medical officerMale0.0Global Dominance: 0.00%
Dr. David Hughes is the chief medical officer at Pharmac, who has been involved in evaluating the funding process for Trikafta. He plays a key role in assessing the health needs of patients with cystic fibrosis and determining the prioritization of treatments within the organization's funding framework.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Hughes is the Pharmac advice and assessment director and chief medical officer discussing the funding of cancer medicines.
Breast cancer: Pāpāmoa retiree with ‘incurable’ diagnosis calls for Enhertu drug fundingThe New Zealand Herald – country’s largest newspaper, est. 1863·
New Zealand· 2025-06-09
New Zealand· 2025-06-09
Dr David Hughes is the chief medical officer at Pharmac who discussed the next steps for the funding recommendation.
Cystic fibrosis: Tauranga mother hopes Trikafta will be funded for pre-schoolersThe New Zealand Herald – country’s largest newspaper, est. 1863·New Zealand· 2025-02-13
New Zealand· 2025-02-13
